Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4967675 | 1.00 | ATM (0.48) | ATMHCAR2TDP1LMNAMAPT | |
| SCHEMBL14829382 | 0.93 | HCAR2 (0.46) | ATMHCAR2TDP1LMNAMAPT | |
| SCHEMBL15991182 | 0.93 | HCAR2 (0.46) | ATMHCAR2TDP1LMNAMAPT | |
| SCHEMBL15991181 | 0.93 | HCAR2 (0.46) | ATMHCAR2TDP1LMNAMAPT | |
| SCHEMBL14152029 | 0.93 | HCAR2 (0.46) | ATMHCAR2TDP1LMNAMAPT | |
| SCHEMBL11748614 | 0.90 | ATM (0.59) | ATMHCAR2TDP1LMNAMAPT | |
| SCHEMBL6903301 | 0.90 | ATM (0.59) | ATMHCAR2TDP1LMNAMAPT | |
| SCHEMBL6903305 | 0.90 | ATM (0.59) | ATMHCAR2TDP1LMNAMAPT | |
| SCHEMBL182415 | 0.88 | TDP1 (0.51) | ATMHCAR2TDP1LMNAGSTP1 | |
| SCHEMBL182416 | 0.88 | TDP1 (0.51) | ATMHCAR2TDP1LMNAGSTP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2692776-B1 | ORGANOPOLYSILOXANE, METHOD FOR PRODUCING SAME, AND CURABLE RESIN COMPOSITION CONTAINING ORGANOPOLYSILOXANE | ASAHI CHEMICAL IND (JP) | 2017-02-22 | — | — | EP | disclosed |
| US-8822724-B2 | Method for producing carboxylic acid amide | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-09-02 | — | — | US | disclosed |
| EP-2692776-A1 | ORGANOPOLYSILOXANE, METHOD FOR PRODUCING SAME, AND CURABLE RESIN COMPOSITION CONTAINING ORGANOPOLYSILOXANE | Asahi Kasei Chemicals Corporation (JP) | 2014-02-05 | — | — | EP | disclosed |
| EP-2599769-A1 | METHOD FOR PRODUCING CARBOXYLIC ACID AMIDE | Sumitomo Chemical Company Limited (JP) | 2013-06-05 | — | — | EP | disclosed |
| US-20130123505-A1 | METHOD FOR PRODUCING CARBOXYLIC ACID AMIDE | SUMITOMO CHEMICAL COMPANY, LIMITED | 2013-05-16 | — | — | US | disclosed |
| EP-1460090-B1 | PROCESSES FOR PRODUCTION OF POWDERED FLUORORESINS BEARING CURABLE FUNCTIONAL GROUPS AND COATING COMPOSITIONS CONTAINING THE SAME | ASAHI GLASS CO LTD (JP) | 2008-09-10 | — | — | EP | disclosed |
| US-7144948-B2 | Processes for producing a fluororesin powder having curable functional groups and its coating composition | ASAHI GLASS COMPANY, LIMITED (JP) | 2006-12-05 | — | — | US | disclosed |
| US-20040225060-A1 | Processes for producing a fluororesin powder having curable functional groups and its coating composition | ASAHI GLASS COMPANY LIMITED (JP) | 2004-11-11 | — | — | US | disclosed |
| US-6806333-B2 | TETRAFLUOROETHYLENE COPOLYMER HAVING CO-MONOMERS A VINYL MONOMER WITH A REACTIVE GROUP, (METH)ACRYLIC ACID OR ALKYL ESTER CAPABLE OF FORMING A BOND BY REACTING WITH THE REACTIVE GROUP; COMPATIBILITY, WATERBASED, SOLVENT-FREE | ASAHI GLASS COMPANY, LIMITED (JP) | 2004-10-19 | — | — | US | disclosed |
| EP-1460090-A1 | PROCESSES FOR PRODUCTION OF POWDERED FLUORORESINS BEARING CURABLE FUNCTIONAL GROUPS AND COATING COMPOSITIONS CONTAINING THE SAME | Asahi Glass Company, Limited (JP) | 2004-09-22 | — | — | EP | disclosed |
| US-20030114616-A1 | Aqueous dispersion of fluorocopolymer | ASAHI GLASS COMPANY LIMITED (JP) | 2003-06-19 | — | — | US | disclosed |
| EP-1306397-A1 | AQUEOUS FLUOROCOPOLYMER DISPERSION | ASAHI GLASS COMPANY LTD. (JP) | 2003-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130123505-A1 | METHOD FOR PRODUCING CARBOXYLIC ACID AMIDE | HCAR2, NAAA, FAAH2 | ATM 3937/4885HCAR2 1/4885TDP1 4705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.